One important mediator of adaptive resistance in mutant BRAF melanoma cells is the lineage-specific transcription factor, FOXD3, which undergoes rapid transcriptional induction upon inhibition of ERK1/2 signaling and activates the ERBB3/PI3K/AKT pathway13. This evidence concerns the gene MAPK3 and melanoma.